Please Wait
Applying Filters...
menu
    • menu
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Avexitide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amylyx Pharma Reveals 2025 Financial Performance
    Amylyx Pharma Reveals 2025 Financial Performance

    03 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260303771323/en/Amylyx-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results

    BUSINESSWIRE
    03 Mar 2026
    Share Share
    Amylyx Pharma Reveals Q3 2025 Financials
    Amylyx Pharma Reveals Q3 2025 Financials

    06 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251106437649/en/Amylyx-Pharmaceuticals-Reports-Third-Quarter-2025-Financial-Results

    BUSINESSWIRE
    06 Nov 2025
    Share Share
    Amylyx Shares Avexitide Bariatric Data at ENDO 2025
    Amylyx Shares Avexitide Bariatric Data at ENDO 2025

    13 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250713408050/en/Amylyx-Pharmaceuticals-Presents-New-Exploratory-Analyses-from-Phase-2-and-Phase-2b-Clinical-Trials-of-Avexitide-in-Post-Bariatric-Hypoglycemia-at-ENDO-2025

    BUSINESSWIRE
    13 Jul 2025
    Share Share
    Amylyx to Present Avexitide Data at ENDO 2025
    Amylyx to Present Avexitide Data at ENDO 2025

    08 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250708428715/en/Amylyx-Pharmaceuticals-to-Host-Event-to-Discuss-Post-bariatric-Hypoglycemia-and-Avexitide-at-ENDO-2025

    BUSINESSWIRE
    08 Jul 2025
    Share Share
    Amylyx Unveils Phase 3 LUCIDITY Trial For Avexitide In Hypoglycemia
    Amylyx Unveils Phase 3 LUCIDITY Trial For Avexitide In Hypoglycemia

    04 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241203046765/en

    BUSINESSWIRE
    04 Dec 2024
    Share Share
    Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results
    Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results

    08 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240808415481/en

    BUSINESSWIRE
    08 Aug 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.